Conclusion:
In conclusion, we found that, unlike previous hemodialysis studies, age
and the presence of dyspnea as the complaint of presentation are
determinants of in-hospital mortality in our study. We did not find a
significant difference in laboratory values between the patients who
survived and died. COVID-19 infection is a risk factor for RT and HD
patients. This study was conducted before the vaccination program. Since
both HD and RT patients are immunosuppressed, on-time contact with the
nephrologist and/or transplant surgeon and admission to the hospital in
case of doubt for COVID-19 infection and inclusion of transplant
patients to the vaccination programs can reduce the mortality. However,
large-scale prospective randomized studies are needed.